SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Christian P. Müller, Judith R. Homberg, The role of serotonin in drug use and addiction, Behavioural Brain Research, 2015, 277, 146

    CrossRef

  2. 2
    M Kołaczkowski, P Mierzejewski, P Bieńkowski, A Wesołowska, A Newman-Tancredi, ADN-1184 a monoaminergic ligand with 5-HT6/7 receptor antagonist activity: pharmacological profile and potential therapeutic utility, British Journal of Pharmacology, 2014, 171, 4
  3. 3
    Cullen L Schmid, John M Streicher, Herbert Y Meltzer, Laura M Bohn, Clozapine Acts as an Agonist at Serotonin 2A Receptors to Counter MK-801-Induced Behaviors through a βArrestin2-Independent Activation of Akt, Neuropsychopharmacology, 2014, 39, 8, 1902

    CrossRef

  4. 4
    Yoshihiro Oyamada, Masakuni Horiguchi, Lakshmi Rajagopal, Masanori Miyauchi, Herbert Y. Meltzer, Combined serotonin (5-HT)1A agonism, 5-HT2A and dopamine D2 receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats, Behavioural Brain Research, 2014,

    CrossRef

  5. 5
    Jing Qiao, Qinglin Zhang, Ming Li, Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2014, 48, 177

    CrossRef

  6. 6
    Mark J. Millan, Kevin Fone, Thomas Steckler, William P. Horan, Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment, European Neuropsychopharmacology, 2014, 24, 5, 645

    CrossRef

  7. 7
    Marzena Maćkowiak, Rafał Guzik, Dorota Dudys, Ewelina Bator, Krzysztof Wędzony, MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex, Pharmacological Reports, 2013, 65, 5, 1112

    CrossRef

  8. 8
    Rongyin Qin, Yingzhu Chen, Ming Li, Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity, Neuropharmacology, 2013, 75, 356

    CrossRef

  9. 9
    Eiichi Jodo, The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: A model for schizophrenia, Journal of Physiology-Paris, 2013, 107, 6, 434

    CrossRef

  10. 10
    Snezana Kusljic, Maarten Van Den Buuse, Differential role of serotonin projections from the dorsal and median raphe nuclei in phencyclidine-induced hyperlocomotion and fos-like immunoreactivity in rats, Synapse, 2012, 66, 10
  11. 11
    Changjiu Zhao, Tao Sun, Ming Li, Neural basis of the potentiated inhibition of repeated haloperidol and clozapine treatment on the phencyclidine-induced hyperlocomotion, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2012, 38, 2, 175

    CrossRef

  12. 12
    Masakuni Horiguchi, Kayleen E Hannaway, Adesewa E Adelekun, Karu Jayathilake, Herbert Y Meltzer, Prevention of the Phencyclidine-Induced Impairment in Novel Object Recognition in Female Rats by Co-Administration of Lurasidone or Tandospirone, a 5-HT1A Partial Agonist, Neuropsychopharmacology, 2012, 37, 10, 2175

    CrossRef

  13. 13
    Noemí Santana, Eva Troyano-Rodriguez, Guadalupe Mengod, Pau Celada, Francesc Artigas, Activation of Thalamocortical Networks by the N-methyl-D-aspartate Receptor Antagonist Phencyclidine: Reversal by Clozapine, Biological Psychiatry, 2011, 69, 10, 918

    CrossRef

  14. 14
    István Gyertyán, Béla Kiss, Katalin Sághy, Judit Laszy, Györgyi Szabó, Tamás Szabados, Larisza I. Gémesi, Gabriella Pásztor, Mária Zájer-Balázs, Margit Kapás, Éva Ágai Csongor, György Domány, Károly Tihanyi, Zsolt Szombathelyi, Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents, Neurochemistry International, 2011, 59, 6, 925

    CrossRef

  15. 15
    Adrian Newman-Tancredi, Mark S. Kleven, Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties, Psychopharmacology, 2011, 216, 4, 451

    CrossRef

  16. You have free access to this content16
    J Kehr, F Ichinose, S Yoshitake, M Goiny, T Sievertsson, F Nyberg, T Yoshitake, Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats, British Journal of Pharmacology, 2011, 164, 8
  17. 17
    Nicholas Seneca, Sjoerd J. Finnema, István Laszlovszky, Béla Kiss, Attila Horváth, Gabriella Pásztor, Margó Kapás, István Gyertyán, Sándor Farkas, Robert B. Innis, Christer Halldin, Balázs Gulyás, Occupancy of dopamine D2 and D3 and serotonin 5-HT1A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography, Psychopharmacology, 2011, 218, 3, 579

    CrossRef

  18. 18
    Sylvia Navailles, Philippe De Deurwaerdère, Presynaptic control of serotonin on striatal dopamine function, Psychopharmacology, 2011, 213, 2-3, 213

    CrossRef

  19. 19
    Herbert Y. Meltzer, Masakuni Horiguchi, Bill W. Massey, The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment, Psychopharmacology, 2011, 213, 2-3, 289

    CrossRef

  20. 20
    HY Meltzer, BW Massey, The role of serotonin receptors in the action of atypical antipsychotic drugs, Current Opinion in Pharmacology, 2011, 11, 1, 59

    CrossRef

  21. 21
    Ming Li, Erik He, Nick Volf, Time course of the attenuation effect of repeated antipsychotic treatment on prepulse inhibition disruption induced by repeated phencyclidine treatment, Pharmacology Biochemistry and Behavior, 2011, 98, 4, 559

    CrossRef

  22. 22
    Tao Sun, Changjiu Zhao, Gang Hu, Ming Li, Iptakalim: A potential antipsychotic drug with novel mechanisms?, European Journal of Pharmacology, 2010, 634, 1-3, 68

    CrossRef

  23. 23
    F. Artigas, The prefrontal cortex: a target for antipsychotic drugs, Acta Psychiatrica Scandinavica, 2010, 121, 1
  24. 24
    Christian P. Müller, Martin E. Pum, Gunter Schumann, Joseph P. Huston, Handbook of the Behavioral Neurobiology of Serotonin, 2010,

    CrossRef

  25. 25
    Mani N. Pavuluri, David B. Henry, Melissa Moss, Tahseen Mohammed, Julie A. Carbray, John A. Sweeney, Effectiveness of Lamotrigine in Maintaining Symptom Control in Pediatric Bipolar Disorder, Journal of Child and Adolescent Psychopharmacology, 2009, 19, 1, 75

    CrossRef

  26. 26
    Satoru Yoshikawa, Nana Hareyama, Ken Ikeda, Takahiro Kurokawa, Mayumi Nakajima, Kaoru Nakao, Hidenori Mochizuki, Hiroshi Ichinose, Effects of TRK-820, a selective kappa opioid receptor agonist, on rat schizophrenia models, European Journal of Pharmacology, 2009, 606, 1-3, 102

    CrossRef

  27. 27
    Carolina Chavez, Andrea Gogos, Margaret E. Jones, Maarten van den Buuse, Psychotropic drug-induced locomotor hyperactivity and prepulse inhibition regulation in male and female aromatase knockout (ArKO) mice: role of dopamine D1 and D2 receptors and dopamine transporters, Psychopharmacology, 2009, 206, 2, 267

    CrossRef

  28. 28
    Tao Sun, Gang Hu, Ming Li, Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: Relevance to animal models of antipsychotic drugs, European Journal of Pharmacology, 2009, 602, 2-3, 334

    CrossRef

  29. 29
    Xavier López-Gil, Francesc Artigas, Albert Adell, Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action, The International Journal of Neuropsychopharmacology, 2009, 12, 04, 487

    CrossRef

  30. 30
    I. Gaisler-Salomon, L. Diamant, C. Rubin, I. Weiner, Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered, Psychopharmacology, 2008, 196, 2, 255

    CrossRef

  31. 31
    Alberto Del Arco, Gregorio Segovia, Francisco Mora, Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity, Psychopharmacology, 2008, 201, 3, 325

    CrossRef

  32. 32
    Mark J. Millan, Mauricette Brocco, Cognitive Impairment in Schizophrenia: a Review of Developmental and Genetic Models, and Pro-cognitive Profile of the Optimised D3> D2Antagonist, S33138, Thérapie, 2008, 63, 3, 187

    CrossRef

  33. 33
    Lucila Kargieman, NoemÍ Santana, Guadalupe Mengod, Pau Celada, Francesc Artigas, NMDA antagonist and antipsychotic actions in cortico-subcortical circuits, Neurotoxicity Research, 2008, 14, 2-3, 129

    CrossRef

  34. 34
    María Cecilia Scorza, María Noel Meikle, Ximena López Hill, Analía Richeri, Daniel Lorenzo, Francesc Artigas, Prefrontal cortex lesions cause only minor effects on the hyperlocomotion induced by MK-801 and its reversal by clozapine, The International Journal of Neuropsychopharmacology, 2008, 11, 04

    CrossRef

  35. 35
    Marc N Potenza, Edward S Brodkin, Bao-Zhu Yang, Shari G Birnbaum, Eric J Nestler, Joel Gelernter, Quantitative Trait Locus Analysis Identifies Rat Genomic Regions Related to Amphetamine-Induced Locomotion and Gαi3 Levels in Nucleus Accumbens, Neuropsychopharmacology, 2008, 33, 11, 2735

    CrossRef

  36. 36
    T. Katayama, E. Jodo, Y. Suzuki, K.-Y. Hoshino, S. Takeuchi, Y. Kayama, Activation of medial prefrontal cortex neurons by phencyclidine is mediated via AMPA/kainate glutamate receptors in anesthetized rats, Neuroscience, 2007, 150, 2, 442

    CrossRef

  37. 37
    Przemyslaw Nowak, Aleksandra Bortel, Joanna Dabrowska, Joanna Oswiecimska, Marzena Drosik, Adam Kwiecinski, Józef Opara, Richard M. Kostrzewa, Ryszard Brus, Amphetamine and mCPP Effects on Dopamine and Serotonin Striatalin vivo Microdialysates in an Animal Model of Hyperactivity, Neurotoxicity Research, 2007, 11, 2, 131

    CrossRef

  38. 38
    Xavier López-Gil, Zoila Babot, Mercè Amargós-Bosch, Cristina Suñol, Francesc Artigas, Albert Adell, Clozapine and Haloperidol Differently Suppress the MK-801-Increased Glutamatergic and Serotonergic Transmission in the Medial Prefrontal Cortex of the Rat, Neuropsychopharmacology, 2007, 32, 10, 2087

    CrossRef

  39. 39
    Tomohiro Abekawa, Koki Ito, Tsukasa Koyama, Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic, Naunyn-Schmiedeberg's Archives of Pharmacology, 2007, 375, 4, 261

    CrossRef

  40. 40
    M. Pum, R. J. Carey, J. P. Huston, C. P. Müller, Dissociating effects of cocaine and d-amphetamine on dopamine and serotonin in the perirhinal, entorhinal, and prefrontal cortex of freely moving rats, Psychopharmacology, 2007, 193, 3, 375

    CrossRef

  41. 41
    R Depoortère, L Bardin, A L Auclair, M S Kleven, E Prinssen, F Colpaert, B Vacher, A Newman-Tancredi, F15063, a compound with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties: (II) Activity in models of positive symptoms of schizophrenia, British Journal of Pharmacology, 2007, 151, 2
  42. 42
    Laurent Bardin, Agn??s Auclair, Mark S. Kleven, Eric P.M. Prinssen, Wouter Koek, Adrian Newman-Tancredi, Ronan Depoort??re, Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics, Behavioural Pharmacology, 2007, 18, 2, 103

    CrossRef

  43. 43
    Christian P. Müller, Robert J. Carey, Joseph P. Huston, Maria A. De Souza Silva, Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors, Progress in Neurobiology, 2007, 81, 3, 133

    CrossRef

  44. 44
    Julie G. Hensler, Serotonergic modulation of the limbic system, Neuroscience & Biobehavioral Reviews, 2006, 30, 2, 203

    CrossRef

  45. 45
    M.J. Millan, F. Panayi, J.M. Rivet, B. Di Cara, L. Cistarelli, R. Billiras, S. Girardon, A. Gobert, Handbook of Microdialysis - Methods, Applications and Perspectives, 2006,

    CrossRef

  46. 46
    Mark J. Millan, N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives, Psychopharmacology, 2005, 179, 1, 30

    CrossRef

  47. 47
    Philippe De Deurwaerdère, Delphine Moison, Sylvia Navailles, Grégory Porras, Umberto Spampinato, Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens, Journal of Neurochemistry, 2005, 94, 1
  48. 48
    Agnès Auclair, Candice Drouin, Susanna Cotecchia, Jacques Glowinski, Jean-Pol Tassin, 5-HT2A and α1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants, European Journal of Neuroscience, 2004, 20, 11
  49. 49
    Christian W. Kreipke, Paul D. Walker, NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulation, Synapse, 2004, 53, 1
  50. 50
    Lucinda J. Steward, Matthew D. Kennedy, Brian J. Morris, Judith A. Pratt, The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors, Neuropharmacology, 2004, 47, 4, 527

    CrossRef

  51. 51
    Grégory Porras, Philippe De Deurwaerdère, Delphine Moison, Umberto Spampinato, Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum, European Journal of Neuroscience, 2003, 17, 4
  52. 52
    Eiichi Jodo, Yoshiaki Suzuki, Satoshi Takeuchi, Shin-ichi Niwa, Yukihiko Kayama, Different effects of phencyclidine and methamphetamine on firing activity of medial prefrontal cortex neurons in freely moving rats, Brain Research, 2003, 962, 1-2, 226

    CrossRef

  53. 53
    Leslie L Devaud, Effects of ethanol or rimcazole on dizocilpine maleate–induced behaviors in male and female rats, Alcohol, 2003, 29, 2, 69

    CrossRef

  54. 54
    A Dekeyne, L Iob, M.J Millan, Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907, Neuropharmacology, 2003, 44, 5, 604

    CrossRef

  55. 55
    Grégory Porras, Vincenzo Di Matteo, Philippe De Deurwaerdère, Ennio Esposito, Umberto Spampinato, Central serotonin4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine, Neuropharmacology, 2002, 43, 7, 1099

    CrossRef

  56. 56
    Leo Gotoh, Noriko Kawanami, Tatsuo Nakahara, Hisao Hondo, Keisuke Motomura, Eiko Ohta, Izumi Kanchiku, Toshihide Kuroki, Makoto Hirano, Hideyuki Uchimura, Effects of the adenosine A1 receptor agonist N6-cyclopentyladenosine on phencyclidine-induced behavior and expression of the immediate-early genes in the discrete brain regions of rats, Molecular Brain Research, 2002, 100, 1-2, 1

    CrossRef

  57. 57
    George R Breese, Darin J Knapp, Sheryl S Moy, Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness, Neuroscience & Biobehavioral Reviews, 2002, 26, 4, 441

    CrossRef

  58. 58
    Akitomo Mori, Yukihiro Noda, Taku Nagai, Takayoshi Mamiya, Hiroshi Furukawa, Toshitaka Nabeshima, Involvement of dopaminergic system in the nucleus accumbens in the discriminative stimulus effects of phencyclidine, Neuropharmacology, 2002, 42, 6, 764

    CrossRef

  59. 59
    Brian J Jones, Thomas P Blackburn, The medical benefit of 5-HT research, Pharmacology Biochemistry and Behavior, 2002, 71, 4, 555

    CrossRef

  60. 60
    Pamela B Yang, Alan C Swann, Nachum Dafny, Valproate prevents the induction and the expression of MK-801 sensitization, Brain Research, 2002, 954, 2, 151

    CrossRef

  61. 61
    H. Qiao, Y. Noda, H. Kamei, T. Nagai, H. Furukawa, H. Miura, Y. Kayukawa, T. Ohta, T. Nabeshima, Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment, Neuroreport, 2001, 12, 1, 11

    CrossRef

  62. 62
    Toshiaki Habara, Takashi Hamamura, Masahito Miki, Kazuyo Ohashi, Shigetoshi Kuroda, M100907, a selective 5-HT2A receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain, European Journal of Pharmacology, 2001, 417, 3, 189

    CrossRef

  63. 63
    Shinji Takahashi, Kazutoshi Horikomi, Takeshi Kato, MS-377, a novel selective σ1 receptor ligand, reverses phencyclidine-induced release of dopamine and serotonin in rat brain, European Journal of Pharmacology, 2001, 427, 3, 211

    CrossRef

  64. 64
    S Sripada, O Gaytan, A Swann, N Dafny, The role of MK-801 in sensitization to stimulants, Brain Research Reviews, 2001, 35, 2, 97

    CrossRef

  65. 65
    C. Anthony Altar, Arnold R. Martin, Andrew Thurkauf, Antipsychotic Agents, Burger's Medicinal Chemistry and Drug Discovery,